Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2019 Financial Results

Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 17c

November 5, 2019 7:37 AM EST

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q3 EPS of ($0.63), $0.17 better than the analyst estimate of ($0.80).

I am pleased with the significant progress we have made in the third quarter across our commercial, regulatory, and clinical initiatives, said Dr. Sharon Mates, Chairman and CEO of... More